Testing my blood sugar is a task I have done faithfully, frequently, and yet without much enthusiasm every day for more than 20 years. It has been like brushing my teeth – I know it’s good for me, so I do it. I’m like a robot. And that’s the problem: I check my blood sugar (at least six times a day), I make a decision in the moment (e.g. take insulin, or treat a low), and then I put the number out of my mind (it’s stored in the meter, right?).
Category: CGMs, Meters & Pumps
Tandem announced today, at the 72nd Scientific Sessions of the American Diabetes Association, that it will begin accepting orders for the t:slimTM Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen...
In the next step toward the development of an artificial pancreas, Medtronic announced that it has filed the final module of its Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration for the MiniMed 530G system featuring Threshold Suspend Automation. If approved...
Symphony is a needle free, wireless, transdermal continuous glucose monitoring system designed to provide accurate, real-time continuous blood glucose data...
Sanofi US announced that the iBGStar Blood Glucose Monitoring System
JDRF and Dexcom announced that they have formed a partnership whose goal is to accelerate the development of a novel wireless “smart transmitter” that would allow a continuous glucose monitor (CGM) system to communicate directly with an artificial pancreas...
Lane Desborough, Product Strategist at Medtronic, led a discussion of the closed loop system, and what his team faces in designing one...
Although I live in an apartment with cat and dog hair scattered around and all the dirt that three little boys bring home, I'm a clean-freak at heart. I clean the keyboard on my laptop, I've been known to wipe down my cell phone, and recently I've thought quite a bit about the fact that Mike's insulin pump, which he's had for about nine months, is long overdue for a wash down...
Medtronic, Inc. today announced the international market launch of CareLink® Pro 3 Therapy Management Software, the first software program to offer advanced decision support to healthcare professionals managing diabetes. The software analyzes data from a patient’s insulin pump, continuous glucose monitoring...
Abbott announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients....